Independence Blue Cross proudly supports the Prostate Cancer Foundation (PCF) in its ongoing efforts to promote awareness of prostate cancer throughout the Philadelphia region and nationwide.
According to PCF, in 2017 alone it is estimated that more than 161,000 men will be diagnosed with prostate cancer, and more than 27,000 will die from the disease. In addition, PCF reports that men of African descent are 73 percent more likely to develop prostate cancer and more than twice as likely as Caucasian men to die from the disease. In fact, prostate cancer is the most common non-skin cancer in America, affecting one in eight men.
Independence’s “Go Blue” campaign extends beyond Prostate Cancer Awareness Month in September and includes plans for on-going associate, member, and community educational seminars and events.
PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Founded in 1993, PCF has raised more than $670 million and provided funding to more than 2,000 research programs at nearly 200 cancer centers and universities. The PCF global research enterprise now extends to 19 countries.